Garth Lees-Rolfe

Insider Reports History

Location
Lexington, MA
Signature
/s/ Garth Lees-Rolfe
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Garth Lees-Rolfe:

Company Role Class Num Shares Value Price $ Report Date Ownership
Inhibikase Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 90,000 21 Jan 2025 Direct

Insider Reports Filed by Garth Lees-Rolfe

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LUDG LUDWIG ENTERPRISES, INC. 23 Jun 2025 0 $0 3 Director 26 Jun 2025, 15:29
IKT Inhibikase Therapeutics, Inc. 21 Jan 2025 4 $0 4 Chief Financial Officer 22 Jan 2025, 16:05
IKT Inhibikase Therapeutics, Inc. 03 Jan 2025 3 $0 4 Chief Financial Officer 07 Jan 2025, 18:43
IKT Inhibikase Therapeutics, Inc. 01 Apr 2024 1 $0 4 Chief Financial Officer 02 Apr 2024, 17:14
IKT Inhibikase Therapeutics, Inc. 01 Apr 2024 0 $0 3 Chief Financial Officer 02 Apr 2024, 17:12